Difference between revisions of "Hürthle cell neoplasm"

Jump to navigation Jump to search
1,119 bytes added ,  18:08, 21 December 2015
no edit summary
Line 1: Line 1:
'''Hürthle cell neoplasm''' is a rare tumour of the [[thyroid gland]] that can have a benign or malignant behaviour.
'''Hürthle cell neoplasm''' is a rare tumour of the [[thyroid gland]] that can have a benign or malignant behaviour.


It may be referred to as ''[[oncocytic neoplasm]]''.
It may be referred to as ''[[oncocytic neoplasm]]''. They are generally considered a subset of [[follicular neoplasm]],<ref name=pmid26530486>{{Cite journal  | last1 = Wei | first1 = S. | last2 = LiVolsi | first2 = VA. | last3 = Montone | first3 = KT. | last4 = Morrissette | first4 = JJ. | last5 = Baloch | first5 = ZW. | title = PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma. | journal = Endocr Pathol | volume = 26 | issue = 4 | pages = 365-9 | month = Dec | year = 2015 | doi = 10.1007/s12022-015-9403-6 | PMID = 26530486 }}</ref><ref name=pmid24753500>{{Cite journal  | last1 = Ustun | first1 = B. | last2 = Chhieng | first2 = D. | last3 = Van Dyke | first3 = A. | last4 = Carling | first4 = T. | last5 = Holt | first5 = E. | last6 = Udelsman | first6 = R. | last7 = Adeniran | first7 = AJ. | title = Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification. | journal = Cancer Cytopathol | volume = 122 | issue = 7 | pages = 536-45 | month = Jul | year = 2014 | doi = 10.1002/cncy.21425 | PMID = 24753500 }}</ref> which includes [[follicular thyroid carcinoma]] and [[follicular thyroid adenoma]].


'''Hürthle cell carcinoma''' and '''Hürthle cell adenoma''' redirect to here.
'''Hürthle cell carcinoma''' and '''Hürthle cell adenoma''' redirect to here.
==General==
==General==
*Incidence: uncommon.
*Incidence: uncommon.
48,460

edits

Navigation menu